Cargando…

Review of docetaxel in the treatment of gastric cancer

Gastric cancer is a global health problem accounting for 800,000 cancer related deaths annually. Often diagnosed at an advanced stage, the treatment of gastric cancer with chemotherapy is directed towards palliating cancer related symptoms with only modest improvements in survival. In addition, no r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tetzlaff, Eric D, Cheng, Jonathan D, Ajani, Jaffer A
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621422/ https://www.ncbi.nlm.nih.gov/pubmed/19209281

Ejemplares similares

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
por: Cen, Putao, et al.
Publicado: (2008)

Targeted literature review of the global burden of gastric cancer
por: Casamayor, Montserrat, et al.
Publicado: (2018)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

Recent advances in the management of gastric adenocarcinoma patients
por: Rogers, Jane E, et al.
Publicado: (2023)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Drug resistance and Cancer stem cells
por: Li, Yuan, et al.
Publicado: (2021)

The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Evolution of gastric surgery techniques and outcomes
por: Shiozaki, Hironori, et al.
Publicado: (2016)

Is endoscopic ultrasound examination necessary in the management of esophageal cancer?
por: DaVee, Tomas, et al.
Publicado: (2017)

Therapeutic Advances in the Treatment of Gastroesophageal Cancers
por: Li, Jenny J., et al.
Publicado: (2023)

Weekly docetaxel in the treatment of metastatic breast cancer
por: Palmeri, Laura, et al.
Publicado: (2008)

Treatment of Gastric Adenocarcinoma May Differ Among Hospital Types in the United States, a Report from the National Cancer Data Base
por: Reid-Lombardo, Kaye M., et al.
Publicado: (2007)

Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
por: Rogers, Jane E., et al.
Publicado: (2023)

Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges
por: Yamashita, Kohei, et al.
Publicado: (2020)

Medical management of gastric cancer: a 2017 update
por: Charalampakis, Nikolaos, et al.
Publicado: (2017)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
por: Jin, Jiankang, et al.
Publicado: (2023)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
por: Sinibaldi, Victoria J
Publicado: (2007)

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
por: A. Razak, S. Aishah, et al.
Publicado: (2021)

Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
por: Charalampakis, Nikolaos, et al.
Publicado: (2022)

Overcoming docetaxel resistance in prostate cancer: a perspective review
por: Hwang, Clara
Publicado: (2012)

Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020)

Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial
por: Tebbutt, N C, et al.
Publicado: (2013)

Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook
por: Jin, Zixian, et al.
Publicado: (2021)

Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin
por: Takeuchi, Madoka, et al.
Publicado: (2019)

Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer
por: Stark, Alexander P., et al.
Publicado: (2020)

Endoscopic management of esophageal cancer
por: Ahmed, Osman, et al.
Publicado: (2019)

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
por: Pant, Shubham, et al.
Publicado: (2008)

Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation
por: Varnai, Reka, et al.
Publicado: (2019)

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance
por: Harada, Kazuto, et al.
Publicado: (2018)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors
por: Rogers, Jane E., et al.
Publicado: (2022)

Molecular mechanisms of docetaxel resistance in prostate cancer
por: Sekino, Yohei, et al.
Publicado: (2020)

Docetaxel in the treatment of squamous cell carcinoma of the head and neck
por: Rapidis, Alexander, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_le9hd3pv47m52gmscvgub9n55a